Market Overview

Q4 Earnings Outlook For Pfizer

Share:

Pfizer (NYSE: PFE) unveils its next round of earnings this Tuesday, Jan. 29. Here is Benzinga's everything-that-matters guide for this Tuesday's Q4 earnings announcement

Earnings and Revenue

Pfizer EPS is expected to be around 64 cents, according to sell-side analysts. Sales will likely be near $13.95 billion.

In the same quarter last year, Pfizer posted a profit of 62 cents on sales of $13.70 billion. Sales would be up 1.8 percent from the year-ago period. Here's how the Pfizer's reported EPS has stacked up against analyst estimates in the past:

 

Quarter Q3 2018 Q2 2018 Q1 2018 Q4 2017
EPS Estimate 0.75 0.74 0.74 0.56
EPS Actual 0.78 0.81 0.77 0.62

Stock Performance

Over the last 52-week period, shares are up 10.05 percent. Given that these returns are generally positive, long-term shareholders can be content going into this earnings release. Analysts have adjusted their estimates higher for EPS and revenues over the past 90 days. Analysts seem to have settled on a Neutral rating with Pfizer. The strength of this rating has maintained conviction over the past three months.

Conference Call

Pfizer is scheduled to hold a conference call at 10:00 a.m. ET and it can be accessed here: https://www.webcaster4.com/Webcast/Page/748/28670

Posted-In: Earnings News

 

Related Articles (PFE)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Q4 Earnings Preview For Polaris Industries

Allergan Q4 Earnings Preview